| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
1996-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06a7245cfcb7dfbeeb16c8dbe329a826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_421672a358b17f0886da75e168f1763c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66af299b2129891f11194fcf6fe88e6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9768ca7904c0a52aa2effbab3b88a6d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea7a92a7bccc2d8a34a5ba41f1d8e8fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba015858679be3841eeeda5bb1747def
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70d5043cc7be074541b6bfde4a8c1cfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49b14ac6ec009ee68e7c9fd0507dfa11 |
| publicationDate |
2003-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0859629-B1 |
| titleOfInvention |
Phosphorylated recombinant human beta casein for inhibition of attachment of h. influenzae to human cells |
| abstract |
A product is provided for inhibiting the attachment of H. influenzae to human cells, such as pharyngeal cells, by contacting the bacilli with phosphorylated recombinant human beta -casein that have at least 3 phosphate groups. The product containing phosphorylated recombinant human beta -casein may be a liquid enteral nutritional product such as infant formula. The enteral nutritional product may be used for the prevention and treatment of otitis media in infants. The phosphorylated recombinant human beta -casein may also be administered as a throat spray or used in nose drops or a spray. 00000 |
| priorityDate |
1995-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |